Stokes & Hubbell Capital Management’s Exact Sciences EXAS Stock Holding History

Stokes & Hubbell Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$372K	Hold	4,300	–	–	0.08%	106
2018 Q4	$271K	Hold	4,300	–	–	0.06%	111
2018 Q3	$339K	Hold	4,300	–	–	0.07%	105
2018 Q2	$257K	Sell	4,300 -1,000	-19%	-$53.8K	0.06%	116
2018 Q1	$214K	Hold	5,300	–	–	0.05%	117
2017 Q4	$278K	Hold	5,300	–	–	0.07%	103
2017 Q3	$250K	Buy	+5,300	New	+$213K	0.06%	103

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Stokes & Hubbell Capital Management's EXAS Position: Q1 2019 in Review

Stokes & Hubbell Capital Management held its Exact Sciences (EXAS) position steady in Q1 2019 at 4,300 shares worth $372K. The position accounts for 0.08% of the portfolio, ranked #106.

Stokes & Hubbell Capital Management first reported a position in EXAS in Q3 2017 and has held it in 7 quarters since. 424 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

Stokes & Hubbell Capital Management held 4,300 shares of Exact Sciences worth $372K as of Q1 2019.
Stokes & Hubbell Capital Management left its Exact Sciences share count unchanged in Q1 2019.
Exact Sciences made up 0.08% of Stokes & Hubbell Capital Management's portfolio in Q1 2019, its #106 holding.
Stokes & Hubbell Capital Management first reported a position in Exact Sciences in Q3 2017 and has held it in 7 quarters since.
424 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on Stokes & Hubbell Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.